Promega SARS-CoV-2 antibody test gets CE Mark

2019 09 16 18 27 8672 Quality Check Mark 400

Promega's SARS-CoV-2 antibody test, Lumit Dx SARS-CoV-2 Immunoassay, has received the CE Mark and is now available in Europe. The test is based on bioluminescence, which Promega believes offers workflow advantages.

The assay is a qualitative IVD test that detects antibodies against the receptor-binding domain antigen within the SARS-CoV-2 spike in serum in less than one hour at room temperature.

Additionally, the bioluminescent test offers a simple add-incubate-read workflow and requires no wash steps.

Page 1 of 34
Next Page